<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562171</url>
  </required_header>
  <id_info>
    <org_study_id>B2012:010</org_study_id>
    <nct_id>NCT01562171</nct_id>
  </id_info>
  <brief_title>Lentils as a Functional Food to Improve Glucose and Decrease Cardiovascular Risk</brief_title>
  <acronym>LEN-0-2012</acronym>
  <official_title>Lentils as a Functional Food to Improve Glucose Tolerance and Decrease Cardiovascular Disease Risk in Hypercholesterolemic Overweight Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glycemic Index Laboratories, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saskatchewan Pulse Growers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compared to control foods, consumption of 3 cups of cooked lentils given weekly for 12 weeks
      will significantly improve glucose tolerance and lower LDL-cholesterol in individuals with
      high cholesterol and obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-site, randomized, controlled, parallel group food study designed to examine
      the health benefits, specifically glucose tolerance, insulin sensitivity and LDL-cholesterol
      in overweight individuals with a high waist circumference and elevated LDL-cholesterol.
      Recruitment will consist of approximately 102 overweight participants (n= 51 participants per
      site, at 2 sites located in Winnipeg and Toronto) with high waist circumference and elevated
      LDL-cholesterol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To examine the effect of lentils on glucose tolerance and LDL-cholesterol.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To examine the effect of lentils on glycated hemoglobin; fasting plasma glucose, insulin, triglycerides, HDL-cholesterol and C-reactive protein.</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>To examine the effect of lentils on vascular responsiveness, and biomarkers of vascular function, inflammation and metabolism.</measure>
    <time_frame>12 Weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Obesity</condition>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Cooked Lentils</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group will be asked to consume food items containing one serving of (0.3 cups) of cooked lentils per day for the first 5 days, followed by one serving of (0.6 cups) of cooked lentils per day 5 times per week (equivalent of 3 cups cooked lentils per week) for the remainder of the 12-week schedule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Potato-Based Foods</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will be asked to consume one serving per day of potato-based foods in matrices similar to those containing lentils in the same 12-week schedule, including the smaller serving size for the first 5 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cooked Lentils</intervention_name>
    <description>Consume food items containing one serving of (0.3 cups) of cooked lentils per day for the first 5 days, followed by one serving of (0.6 cups) of cooked lentils per day 5 times per week (equivalent of 3 cups cooked lentils per week) for the remainder of the 12-week schedule.</description>
    <arm_group_label>Cooked Lentils</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Potato-Based Foods</intervention_name>
    <description>Control - Consumption of one serving per day of potato-based foods in matrices similar to those containing lentils in the same 12-week schedule, including the smaller serving size for the first 5 days.</description>
    <arm_group_label>Potato-Based Foods</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or non-pregnant, non-lactating females aged 30 to 75 years;

          -  Body Mass Index of ≤40 kg/m2 and ≥23 kg/m2 if Asian or ≥25 kg/m2 if non-Asian;

          -  Waist circumference ≥94 cm for males and ≥80 cm for females of Asian ethnicity,and
             ≥102 cm for males and ≥88 cm of non-Asian ethnicity;

          -  Fasting plasma glucose &lt;7 mmol/L;

          -  Fasting triglycerides &lt;4.00 mmol/L and LDL-cholesterol &gt;2.50 mmol/L and &lt;5.00 mmol/L;

          -  Must be on a stable regime for the past 3 months if taking medications to treat
             hypertension or if taking vitamin and mineral/dietary/herbal supplements;

          -  Stable body weight (±3 kg) for the past 3 months

        Exclusion Criteria:

          -  Previous diagnosis of type 2 diabetes;

          -  High pulse consumption (≥2 servings per week);

          -  Presence of liver disease (aspartate transaminase &gt;2 times Upper Normal Limit), renal
             insufficiency (creatinine &gt;1.5 times Upper Normal Limit); inflammatory bowel disease
             or other gastrointestinal disorders influencing gastrointestinal motility or nutrient
             absorption;

          -  Use of medication which influence carbohydrate metabolism (i.e., steroids), or
             medications used to treat diabetes or to lower blood lipids, or any active medical or
             surgical conditions within the past 3 months;

          -  Conditions or medications which are likely to increase the risk to the participants or
             study personnel, or to reduce the ability of the participant to comply with the
             protocol, or affect the results;

          -  History of gastrointestinal reactions or allergies to lentils or potato-based foods,
             or to one or more ingredients in the study foods which significantly limits the number
             of study foods that can be consumed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carla Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>I.H. Asper Clinical Research Institute</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glycemic Index Laboratories, Incorporated</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2N8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.sbrc.ca/ccarm/</url>
    <description>Canadian Centre for Agri-Food Research in Health &amp; Medicine (website)</description>
  </link>
  <reference>
    <citation>Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 9;162(16):1867-72.</citation>
    <PMID>12196085</PMID>
  </reference>
  <reference>
    <citation>Calkin AC, Allen TJ. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention. Am J Cardiovasc Drugs. 2006;6(1):15-40. Review.</citation>
    <PMID>16489846</PMID>
  </reference>
  <reference>
    <citation>Juvenile diabetes Research Foundation (2005) http://www.jdrf.org.au/publications/factsheets/complications.html Accessed July 30, 2009.</citation>
  </reference>
  <reference>
    <citation>Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006 Jan 31;113(4):499-506.</citation>
    <PMID>16449729</PMID>
  </reference>
  <reference>
    <citation>Statistics Canada: http://www.hc-sc.gc.ca/dc-ma/diabete/index_e.html. Accessed July 30, 2009.</citation>
  </reference>
  <reference>
    <citation>Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006 Apr;55(4):1114-20.</citation>
    <PMID>16567536</PMID>
  </reference>
  <reference>
    <citation>Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.</citation>
    <PMID>8366922</PMID>
  </reference>
  <reference>
    <citation>Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.</citation>
    <PMID>9915665</PMID>
  </reference>
  <reference>
    <citation>Wolever TM, Mehling C, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial. Diabetologia. 2008 Sep;51(9):1607-15. doi: 10.1007/s00125-008-1093-x. Epub 2008 Jul 22.</citation>
    <PMID>18648764</PMID>
  </reference>
  <reference>
    <citation>Sievenpiper JL, Kendall CW, Esfahani A, Wong JM, Carleton AJ, Jiang HY, Bazinet RP, Vidgen E, Jenkins DJ. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009 Aug;52(8):1479-95. doi: 10.1007/s00125-009-1395-7. Epub 2009 Jun 13. Review.</citation>
    <PMID>19526214</PMID>
  </reference>
  <reference>
    <citation>Pulse Canada: http://www.pulsecanada.com/uploads/9f/96/9f9658890a7180395b648f83f26978c5/09-Apr-20-Clinical-Trial-release.pdf Accessed July 30, 2009.</citation>
  </reference>
  <reference>
    <citation>Rizkalla SW, Bellisle F, Slama G. Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr. 2002 Dec;88 Suppl 3:S255-62. Review.</citation>
    <PMID>12498625</PMID>
  </reference>
  <reference>
    <citation>Wylie-Rosett J, Segal-Isaacson CJ &amp; Segal-Isaacson A (2004) Obes Res 12: 124S-129S.</citation>
  </reference>
  <reference>
    <citation>Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2005 Nov;8(6):636-40. Review.</citation>
    <PMID>16205465</PMID>
  </reference>
  <reference>
    <citation>Anderson JW, Major AW. Pulses and lipaemia, short- and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr. 2002 Dec;88 Suppl 3:S263-71.</citation>
    <PMID>12498626</PMID>
  </reference>
  <reference>
    <citation>Frick M, Weidinger F. Endothelial function: a surrogate endpoint in cardiovascular studies? Curr Pharm Des. 2007;13(17):1741-50. Review.</citation>
    <PMID>17584104</PMID>
  </reference>
  <reference>
    <citation>Tsuda T, Ueno Y, Aoki H, Koda T, Horio F, Takahashi N, Kawada T, Osawa T. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commun. 2004 Mar 26;316(1):149-57.</citation>
    <PMID>15003523</PMID>
  </reference>
  <reference>
    <citation>Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008 Jul;88(1):38-50.</citation>
    <PMID>18614722</PMID>
  </reference>
  <reference>
    <citation>Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E924-30.</citation>
    <PMID>11595647</PMID>
  </reference>
  <reference>
    <citation>Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007 Jan;30(1):89-94.</citation>
    <PMID>17192339</PMID>
  </reference>
  <reference>
    <citation>Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994 Apr;11(3):286-92.</citation>
    <PMID>8033528</PMID>
  </reference>
  <reference>
    <citation>American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006 Jul 4;114(1):82-96. Epub 2006 Jun 19. Erratum in: Circulation. 2006 Dec 5;114(23):e629. Circulation. 2006 Jul 4;114(1):e27.</citation>
    <PMID>16785338</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2012</study_first_submitted>
  <study_first_submitted_qc>March 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2012</study_first_posted>
  <last_update_submitted>December 11, 2014</last_update_submitted>
  <last_update_submitted_qc>December 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Dr. Carla Taylor</investigator_full_name>
    <investigator_title>Professor, Department of Human Nutritional Sciences</investigator_title>
  </responsible_party>
  <keyword>Overweight</keyword>
  <keyword>Obese</keyword>
  <keyword>Obesity</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Hypercholesterolemia</keyword>
  <keyword>LDL-Cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

